Clinical Trial Update: Fludarabine, Cyclophosphamide, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Umbilical Cord Blood Transplant for Hematologic Cancer [NA]

View source ↗

Summary

This terminated clinical trial evaluated a conditioning regimen of fludarabine, cyclophosphamide, and total-body irradiation followed by cyclosporine and mycoph…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease
• Leukemia
• Lymphoma
• Multiple Myeloma
• Myelodysplastic Myeloproliferative Neoplasms
• Myelodysplastic Syndromes
• Myeloproliferative Neoplasms

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• CYCLOSPORINE (cyclosporine)
• Fludarabine (Fludarabine)
• MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)
• Total Body Irradiation

Snippet

Sponsor: University of Rochester | Conditions: Chronic Myeloproliferative Disorders, Graft Versus Host Disease | NA | Status: TERMINATED | Results posted: 2016-06-27